144 related articles for article (PubMed ID: 19430501)
41. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
42. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
Majhail NS; Parks K; Defor TE; Weisdorf DJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1038-46. PubMed ID: 17067910
[TBL] [Abstract][Full Text] [Related]
43. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
[TBL] [Abstract][Full Text] [Related]
44. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria.
Cruz DN; Bolgan I; Perazella MA; Bonello M; de Cal M; Corradi V; Polanco N; Ocampo C; Nalesso F; Piccinni P; Ronco C;
Clin J Am Soc Nephrol; 2007 May; 2(3):418-25. PubMed ID: 17699446
[TBL] [Abstract][Full Text] [Related]
45. Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor.
Kusumi E; Kami M; Yuji K; Hamaki T; Murashige N; Hori A; Kojima R; Kishi Y; Kim SW; Ueyama J; Miyakoshi S; Tanosaki R; Morinaga S; Mori S; Heike Y; Muto Y; Masuo S; Taniguchi S; Takaue Y
Bone Marrow Transplant; 2004 Apr; 33(7):697-702. PubMed ID: 14755317
[TBL] [Abstract][Full Text] [Related]
46. Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients.
Vieira JM; Castro I; Curvello-Neto A; Demarzo S; Caruso P; Pastore L; Imanishe MH; Abdulkader RC; Deheinzelin D
Crit Care Med; 2007 Jan; 35(1):184-91. PubMed ID: 17080002
[TBL] [Abstract][Full Text] [Related]
47. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
[TBL] [Abstract][Full Text] [Related]
48. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
[TBL] [Abstract][Full Text] [Related]
49. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
50. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
[TBL] [Abstract][Full Text] [Related]
51. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.
Couriel DR; Saliba RM; Giralt S; Khouri I; Andersson B; de Lima M; Hosing C; Anderlini P; Donato M; Cleary K; Gajewski J; Neumann J; Ippoliti C; Rondon G; Cohen A; Champlin R
Biol Blood Marrow Transplant; 2004 Mar; 10(3):178-85. PubMed ID: 14993883
[TBL] [Abstract][Full Text] [Related]
52. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units.
Bagshaw SM; George C; Bellomo R;
Crit Care; 2007; 11(3):R68. PubMed ID: 17588270
[TBL] [Abstract][Full Text] [Related]
53. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
54. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
55. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery.
Hobson CE; Yavas S; Segal MS; Schold JD; Tribble CG; Layon AJ; Bihorac A
Circulation; 2009 May; 119(18):2444-53. PubMed ID: 19398670
[TBL] [Abstract][Full Text] [Related]
56. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
57. Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.
Holler E; Kolb HJ; Greinix H; Perrotin D; Campilho F; Aversa F; Gil L; Cornelissen J; Varanese L; Schacht A; Friese A; Rustige J
Bone Marrow Transplant; 2009 Mar; 43(6):491-7. PubMed ID: 19079317
[TBL] [Abstract][Full Text] [Related]
58. Acute kidney injury following HCT: incidence, risk factors and outcome.
Lopes JA; Jorge S
Bone Marrow Transplant; 2011 Nov; 46(11):1399-408. PubMed ID: 21383682
[TBL] [Abstract][Full Text] [Related]
59. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation.
Boyle JM; Moualla S; Arrigain S; Worley S; Bakri MH; Starling RC; Heyka R; Thakar CV
Am J Kidney Dis; 2006 Nov; 48(5):787-96. PubMed ID: 17059998
[TBL] [Abstract][Full Text] [Related]
60. An evaluation of the RIFLE criteria for acute kidney injury after myeloablative allogeneic haematopoietic stem cell transplantation.
Bao YS; Xie RJ; Wang M; Feng SZ; Han MZ
Swiss Med Wkly; 2011; 141():w13225. PubMed ID: 21769755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
